ANGO

AngioDynamics, Inc.

10.37

USD

ANGO Earnings Reports

Positive Surprise Ratio

ANGO beat 28 of 40 last estimates.

70%

Next Report

Date of Next Report

Mar 31, 2026

Estimate for Q3 26 (Revenue/ EPS)

$78.30M

-$0.11

Implied change from Q2 26 (Revenue/ EPS)

-1.42%

Implied change from Q3 25 (Revenue/ EPS)

+8.75%

-466.67%

AngioDynamics, Inc. earnings per share and revenue

On Jan 06, 2026, ANGO reported earnings of 0.00 USD per share (EPS) for Q2 26, beating the estimate of -0.10 USD, resulting in a 100.00% surprise. Revenue reached 79.43 million, compared to an expected 77.83 million, with a 2.06% difference. The market reacted with a -13.53% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 6 analysts forecast an EPS of -0.11 USD, with revenue projected to reach 78.30 million USD, implying an -- of --% EPS, and decrease of -1.42% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Mesa Laboratories Inc

Report Date

Feb 03, 2026 For Q3 26

Estimate

$0.28

Actual

$3.07

Surprise

+987.88%

Accuray Incorporated

Report Date

Feb 04, 2026 For Q2 26

Estimate

-$0.11

Actual

-$0.11

Surprise

+1.96%

Thermo Fisher Scientific, Inc.

Report Date

Jan 29, 2026 For Q4 25

Estimate

$6.51

Actual

$6.57

Surprise

+0.91%

Intuitive Surgical Inc.

Report Date

Jan 22, 2026 For Q4 25

Estimate

$2.30

Actual

$2.52

Surprise

+9.86%

Idexx Laboratories Inc

Report Date

Feb 02, 2026 For Q4 25

Estimate

$2.98

Actual

$3.08

Surprise

+3.12%

IQVIA Holdings Inc.

Report Date

Feb 05, 2026 For Q4 25

Estimate

$3.43

Actual

$3.42

Surprise

-0.34%

STERIS plc

Report Date

Feb 04, 2026 For Q3 26

Estimate

$2.55

Actual

$2.52

Surprise

-0.99%

Hologic Inc

Report Date

Jan 29, 2026 For Q1 26

Estimate

$1.11

Actual

$1.04

Surprise

-6.45%

FAQ

What were AngioDynamics, Inc.'s earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, AngioDynamics, Inc. reported EPS of $0.00, beating estimates by 100%, and revenue of $79.43M, 2.06% above expectations.

How did the market react to AngioDynamics, Inc.'s Q2 2026 earnings?

The stock price moved down -13.53%, changed from $13.23 before the earnings release to $11.44 the day after.

When is AngioDynamics, Inc. expected to report next?

The next earning report is scheduled for Mar 31, 2026.

What are the forecasts for AngioDynamics, Inc.'s next earnings report?

Based on 6 analysts, AngioDynamics, Inc. is expected to report EPS of -$0.11 and revenue of $78.30M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.